🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a single-centre, 5-cohort, randomized open-label, parallel-gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-31
Trial ID
NCT02184637
Treatments Being Tested
In Papua New Guinea, administration of primaquine (PQ) or tafenoquine (TQ) ...
Status
Not Yet Recruiting
Location
Alexishafen Health Centre
Start Date
2026-04
Trial ID
NCT07060404
A clinical study to assess the efficacy and safety of oral tafenoquine comp...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05947812
Treatments Being Tested
The investigators are proposing a new malaria control strategy to reach the...
Status
Completed
Location
Josiane Muller
Start Date
2022-09-12
Trial ID
NCT05540470
Treatments Being Tested
A clinical study to assess the efficacy and safety of oral tafenoquine comp...
Status
Completed
Location
Deluxe Health Center LLC
Start Date
2021-02-19
Trial ID
NCT04533347
Treatments Being Tested
This is a prospective, double-blind, double-dummy, multicenter, comparative...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-30
Trial ID
NCT02216123
Treatments Being Tested
Phase 2 Open Label Study of Tafenoquine for Treatment of Chronic Babesiosis...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2025-11-18
Trial ID
NCT06656351
Treatments Being Tested
The purpose of this expanded access protocol is to offer a potentially effe...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06478641
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501
In this area of Greater Mekong Subregion (GMS), vivax malaria is the most c...
Status
Recruiting
Location
Shoklo Malaria Research Unit (SMRU)
Start Date
2023-06-26
Trial ID
NCT05788094